Page last updated: 2024-09-03
dioctadecylamidoglycylspermine and Liver Dysfunction
dioctadecylamidoglycylspermine has been researched along with Liver Dysfunction in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Alison, MR; Coutelle, C; Forbes, SJ; Hodgson, HJ; Kobayashi, T; Shiota, A; Themis, M | 1 |
Other Studies
1 other study(ies) available for dioctadecylamidoglycylspermine and Liver Dysfunction
| Article | Year |
|---|---|
Tri-iodothyronine and a deleted form of hepatocyte growth factor act synergistically to enhance liver proliferation and enable in vivo retroviral gene transfer via the peripheral venous system.
Topics: Animals; Cell Division; Genetic Therapy; Genetic Vectors; Glycine; Hepatocyte Growth Factor; Liver; Liver Diseases; Male; Rats; Rats, Wistar; Retroviridae; Spermine; Transfection; Triiodothyronine | 2000 |